The pharma industry is focused on strengthening its foundation, embracing innovation, and future-proofing its path forward.

The pharma industry’s reputation dropped slightly again among patient groups, largely due to drug pricing issues.

Here's a list of the companies that have announced new U.S. investments since Trump took office: Merck on Tuesday said it is ...

Major pharmaceutical companies are committing billions to US manufacturing in an effort to avoid steep tariffs threatened by ...

Like fellow Big Pharmas Eli Lilly and Johnson & Johnson, Amgen is urging the Trump administration to consider tax policy ...

For the second consecutive year, the pharma industry saw its reputation dip among patient advocacy groups, largely due to ...

Biopharmaceutical giant Merck (NYSE: MRK) has broken ground on a $1 billion pharmaceutical manufacturing facility in ...

Drugmaker executives have projected confidence they can mitigate the impact of any levies Trump imposes on the industry. Yet ...

THE EMPLOYEES Nazzareno Mancini is the worker who spoke yesterday on behalf of all Bsp employees. He has witnessed its ...

Medicines and chemicals are huge exports for European Union countries. That makes the sector a weak spot as trade tensions ...

As U.S. and China relations remain tense, concerns are growing over America’s deep reliance on China for critical ...